Company Overview of Arrow Therapeutics, Ltd.
As of February 28, 2007, Arrow Therapeutics, Ltd. was acquired by AstraZeneca PLC. Arrow Therapeutics, Ltd., a biotechnology company, focuses on the discovery and development of anti-viral therapies. It provides RSV604, a small molecule antiviral therapy for respiratory syncytial virus; and AZD2836 and AZD7295 that are compounds used in the treatment of Hepatitis C virus infection. The company was founded in 1998 and is headquartered in London, the United Kingdom.
7 Trinity Street
London, SE1 1DB
Founded in 1998
44 20 7015 1000
44 20 7015 1020
Key Executives for Arrow Therapeutics, Ltd.
Arrow Therapeutics, Ltd. does not have any Key Executives recorded.
Similar Private Companies By Industry
|ADC Biotechnology Ltd||Europe|
|Advanced Gel Technology Limited||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Arrow Therapeutics, Ltd., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.